ArticleJournal of immunology (Baltimore, Md. : 1950)2021

Anti-CD40 Antibodies Fused to CD40 Ligand Have Superagonist Properties.

Valentina Ceglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.